ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Enteral Nutrition Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19W13069
Home | Market Reports | Health| Nutrition
Global Enteral Nutrition Drug Market Research Report 2023
BUY CHAPTERS

Global Enteral Nutrition Drug Market Research Report 2025

Code: QYRE-Auto-19W13069
Report
May 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Hospira
Fresenius Kabi
Danone
Nestlé
B Braun Melsungen AG
Abbott
Baxter
Allergan plc
Actavis
Grifols S A
Vifor Pharma
Knowmedical
Otsuka Pharmaceutical India Private Limited
NUTRICHEM DIÄT + PHARMA GMBH
Delta Drugs

Enteral Nutrition Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Enteral Nutrition Drug Market

Enteral Nutrition Drug Market

The global market for Enteral Nutrition Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Enteral nutrition drugs, also known as enteral nutrition preparations, are a generic term for a variety of products used in clinical enteral nutrition support, whose nutritional composition mainly includes a balance of various proteins, amino acids, sugars, fats, vitamins, minerals, dietary fibre, etc. The raw materials are mainly derived from terrestrial animal and plant extracts.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enteral Nutrition Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enteral Nutrition Drug.
The Enteral Nutrition Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enteral Nutrition Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enteral Nutrition Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Enteral Nutrition Drug Market Report

Report Metric Details
Report Name Enteral Nutrition Drug Market
CAGR 5%
Segment by Type
  • Adults
  • Children
Segment by Application
  • Hospitals
  • Clinics
  • Pharmaceutical Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestlé, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited, NUTRICHEM DIÄT + PHARMA GMBH, Delta Drugs, Baxter, Allergan, Actavis Inc., Grifols, S.A., Vifor Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Enteral Nutrition Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Enteral Nutrition Drug Market report?

Ans: The main players in the Enteral Nutrition Drug Market are Hospira Inc, Fresenius Kabi, Danone, Knowmedical, Nestlé, B. Braun Melsungen AG, Abbott, Otsuka Pharmaceutical India Private Limited, NUTRICHEM DIÄT + PHARMA GMBH, Delta Drugs, Baxter, Allergan, Actavis Inc., Grifols, S.A., Vifor Pharma

What are the Application segmentation covered in the Enteral Nutrition Drug Market report?

Ans: The Applications covered in the Enteral Nutrition Drug Market report are Hospitals, Clinics, Pharmaceutical Companies, Others

What are the Type segmentation covered in the Enteral Nutrition Drug Market report?

Ans: The Types covered in the Enteral Nutrition Drug Market report are Adults, Children

Recommended Reports

Digestive Health Drugs

Enteral Nutrition Supply

Allergy & Weight Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enteral Nutrition Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Adults
1.2.3 Children
1.3 Market by Application
1.3.1 Global Enteral Nutrition Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmaceutical Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Enteral Nutrition Drug Market Perspective (2020-2031)
2.2 Global Enteral Nutrition Drug Growth Trends by Region
2.2.1 Global Enteral Nutrition Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Enteral Nutrition Drug Historic Market Size by Region (2020-2025)
2.2.3 Enteral Nutrition Drug Forecasted Market Size by Region (2026-2031)
2.3 Enteral Nutrition Drug Market Dynamics
2.3.1 Enteral Nutrition Drug Industry Trends
2.3.2 Enteral Nutrition Drug Market Drivers
2.3.3 Enteral Nutrition Drug Market Challenges
2.3.4 Enteral Nutrition Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Enteral Nutrition Drug Players by Revenue
3.1.1 Global Top Enteral Nutrition Drug Players by Revenue (2020-2025)
3.1.2 Global Enteral Nutrition Drug Revenue Market Share by Players (2020-2025)
3.2 Global Enteral Nutrition Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Enteral Nutrition Drug Revenue
3.4 Global Enteral Nutrition Drug Market Concentration Ratio
3.4.1 Global Enteral Nutrition Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enteral Nutrition Drug Revenue in 2024
3.5 Global Key Players of Enteral Nutrition Drug Head office and Area Served
3.6 Global Key Players of Enteral Nutrition Drug, Product and Application
3.7 Global Key Players of Enteral Nutrition Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Enteral Nutrition Drug Breakdown Data by Type
4.1 Global Enteral Nutrition Drug Historic Market Size by Type (2020-2025)
4.2 Global Enteral Nutrition Drug Forecasted Market Size by Type (2026-2031)
5 Enteral Nutrition Drug Breakdown Data by Application
5.1 Global Enteral Nutrition Drug Historic Market Size by Application (2020-2025)
5.2 Global Enteral Nutrition Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Enteral Nutrition Drug Market Size (2020-2031)
6.2 North America Enteral Nutrition Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Enteral Nutrition Drug Market Size by Country (2020-2025)
6.4 North America Enteral Nutrition Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Enteral Nutrition Drug Market Size (2020-2031)
7.2 Europe Enteral Nutrition Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Enteral Nutrition Drug Market Size by Country (2020-2025)
7.4 Europe Enteral Nutrition Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Enteral Nutrition Drug Market Size (2020-2031)
8.2 Asia-Pacific Enteral Nutrition Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Enteral Nutrition Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Enteral Nutrition Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Enteral Nutrition Drug Market Size (2020-2031)
9.2 Latin America Enteral Nutrition Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Enteral Nutrition Drug Market Size by Country (2020-2025)
9.4 Latin America Enteral Nutrition Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Enteral Nutrition Drug Market Size (2020-2031)
10.2 Middle East & Africa Enteral Nutrition Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Enteral Nutrition Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Enteral Nutrition Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Hospira Inc
11.1.1 Hospira Inc Company Details
11.1.2 Hospira Inc Business Overview
11.1.3 Hospira Inc Enteral Nutrition Drug Introduction
11.1.4 Hospira Inc Revenue in Enteral Nutrition Drug Business (2020-2025)
11.1.5 Hospira Inc Recent Development
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Enteral Nutrition Drug Introduction
11.2.4 Fresenius Kabi Revenue in Enteral Nutrition Drug Business (2020-2025)
11.2.5 Fresenius Kabi Recent Development
11.3 Danone
11.3.1 Danone Company Details
11.3.2 Danone Business Overview
11.3.3 Danone Enteral Nutrition Drug Introduction
11.3.4 Danone Revenue in Enteral Nutrition Drug Business (2020-2025)
11.3.5 Danone Recent Development
11.4 Knowmedical
11.4.1 Knowmedical Company Details
11.4.2 Knowmedical Business Overview
11.4.3 Knowmedical Enteral Nutrition Drug Introduction
11.4.4 Knowmedical Revenue in Enteral Nutrition Drug Business (2020-2025)
11.4.5 Knowmedical Recent Development
11.5 Nestlé
11.5.1 Nestlé Company Details
11.5.2 Nestlé Business Overview
11.5.3 Nestlé Enteral Nutrition Drug Introduction
11.5.4 Nestlé Revenue in Enteral Nutrition Drug Business (2020-2025)
11.5.5 Nestlé Recent Development
11.6 B. Braun Melsungen AG
11.6.1 B. Braun Melsungen AG Company Details
11.6.2 B. Braun Melsungen AG Business Overview
11.6.3 B. Braun Melsungen AG Enteral Nutrition Drug Introduction
11.6.4 B. Braun Melsungen AG Revenue in Enteral Nutrition Drug Business (2020-2025)
11.6.5 B. Braun Melsungen AG Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Enteral Nutrition Drug Introduction
11.7.4 Abbott Revenue in Enteral Nutrition Drug Business (2020-2025)
11.7.5 Abbott Recent Development
11.8 Otsuka Pharmaceutical India Private Limited
11.8.1 Otsuka Pharmaceutical India Private Limited Company Details
11.8.2 Otsuka Pharmaceutical India Private Limited Business Overview
11.8.3 Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Introduction
11.8.4 Otsuka Pharmaceutical India Private Limited Revenue in Enteral Nutrition Drug Business (2020-2025)
11.8.5 Otsuka Pharmaceutical India Private Limited Recent Development
11.9 NUTRICHEM DIÄT + PHARMA GMBH
11.9.1 NUTRICHEM DIÄT + PHARMA GMBH Company Details
11.9.2 NUTRICHEM DIÄT + PHARMA GMBH Business Overview
11.9.3 NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Introduction
11.9.4 NUTRICHEM DIÄT + PHARMA GMBH Revenue in Enteral Nutrition Drug Business (2020-2025)
11.9.5 NUTRICHEM DIÄT + PHARMA GMBH Recent Development
11.10 Delta Drugs
11.10.1 Delta Drugs Company Details
11.10.2 Delta Drugs Business Overview
11.10.3 Delta Drugs Enteral Nutrition Drug Introduction
11.10.4 Delta Drugs Revenue in Enteral Nutrition Drug Business (2020-2025)
11.10.5 Delta Drugs Recent Development
11.11 Baxter
11.11.1 Baxter Company Details
11.11.2 Baxter Business Overview
11.11.3 Baxter Enteral Nutrition Drug Introduction
11.11.4 Baxter Revenue in Enteral Nutrition Drug Business (2020-2025)
11.11.5 Baxter Recent Development
11.12 Allergan
11.12.1 Allergan Company Details
11.12.2 Allergan Business Overview
11.12.3 Allergan Enteral Nutrition Drug Introduction
11.12.4 Allergan Revenue in Enteral Nutrition Drug Business (2020-2025)
11.12.5 Allergan Recent Development
11.13 Actavis Inc.
11.13.1 Actavis Inc. Company Details
11.13.2 Actavis Inc. Business Overview
11.13.3 Actavis Inc. Enteral Nutrition Drug Introduction
11.13.4 Actavis Inc. Revenue in Enteral Nutrition Drug Business (2020-2025)
11.13.5 Actavis Inc. Recent Development
11.14 Grifols, S.A.
11.14.1 Grifols, S.A. Company Details
11.14.2 Grifols, S.A. Business Overview
11.14.3 Grifols, S.A. Enteral Nutrition Drug Introduction
11.14.4 Grifols, S.A. Revenue in Enteral Nutrition Drug Business (2020-2025)
11.14.5 Grifols, S.A. Recent Development
11.15 Vifor Pharma
11.15.1 Vifor Pharma Company Details
11.15.2 Vifor Pharma Business Overview
11.15.3 Vifor Pharma Enteral Nutrition Drug Introduction
11.15.4 Vifor Pharma Revenue in Enteral Nutrition Drug Business (2020-2025)
11.15.5 Vifor Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Hospira
Fresenius Kabi
Danone
Nestlé
B Braun Melsungen AG
Abbott
Baxter
Allergan plc
Actavis
Grifols S A
Vifor Pharma
Knowmedical
Otsuka Pharmaceutical India Private Limited
NUTRICHEM DIÄT + PHARMA GMBH
Delta Drugs
List of Tables
 Table 1. Global Enteral Nutrition Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Adults
 Table 3. Key Players of Children
 Table 4. Global Enteral Nutrition Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Enteral Nutrition Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Enteral Nutrition Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Enteral Nutrition Drug Market Share by Region (2020-2025)
 Table 8. Global Enteral Nutrition Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Enteral Nutrition Drug Market Share by Region (2026-2031)
 Table 10. Enteral Nutrition Drug Market Trends
 Table 11. Enteral Nutrition Drug Market Drivers
 Table 12. Enteral Nutrition Drug Market Challenges
 Table 13. Enteral Nutrition Drug Market Restraints
 Table 14. Global Enteral Nutrition Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Enteral Nutrition Drug Market Share by Players (2020-2025)
 Table 16. Global Top Enteral Nutrition Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteral Nutrition Drug as of 2024)
 Table 17. Ranking of Global Top Enteral Nutrition Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Enteral Nutrition Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Enteral Nutrition Drug, Headquarters and Area Served
 Table 20. Global Key Players of Enteral Nutrition Drug, Product and Application
 Table 21. Global Key Players of Enteral Nutrition Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Enteral Nutrition Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Enteral Nutrition Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Enteral Nutrition Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Enteral Nutrition Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Enteral Nutrition Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Enteral Nutrition Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Enteral Nutrition Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Enteral Nutrition Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Enteral Nutrition Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Enteral Nutrition Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Enteral Nutrition Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Enteral Nutrition Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Enteral Nutrition Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Enteral Nutrition Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Enteral Nutrition Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Enteral Nutrition Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Enteral Nutrition Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Enteral Nutrition Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Enteral Nutrition Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Enteral Nutrition Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Enteral Nutrition Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Enteral Nutrition Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Enteral Nutrition Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Hospira Inc Company Details
 Table 47. Hospira Inc Business Overview
 Table 48. Hospira Inc Enteral Nutrition Drug Product
 Table 49. Hospira Inc Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 50. Hospira Inc Recent Development
 Table 51. Fresenius Kabi Company Details
 Table 52. Fresenius Kabi Business Overview
 Table 53. Fresenius Kabi Enteral Nutrition Drug Product
 Table 54. Fresenius Kabi Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 55. Fresenius Kabi Recent Development
 Table 56. Danone Company Details
 Table 57. Danone Business Overview
 Table 58. Danone Enteral Nutrition Drug Product
 Table 59. Danone Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 60. Danone Recent Development
 Table 61. Knowmedical Company Details
 Table 62. Knowmedical Business Overview
 Table 63. Knowmedical Enteral Nutrition Drug Product
 Table 64. Knowmedical Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 65. Knowmedical Recent Development
 Table 66. Nestlé Company Details
 Table 67. Nestlé Business Overview
 Table 68. Nestlé Enteral Nutrition Drug Product
 Table 69. Nestlé Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 70. Nestlé Recent Development
 Table 71. B. Braun Melsungen AG Company Details
 Table 72. B. Braun Melsungen AG Business Overview
 Table 73. B. Braun Melsungen AG Enteral Nutrition Drug Product
 Table 74. B. Braun Melsungen AG Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 75. B. Braun Melsungen AG Recent Development
 Table 76. Abbott Company Details
 Table 77. Abbott Business Overview
 Table 78. Abbott Enteral Nutrition Drug Product
 Table 79. Abbott Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 80. Abbott Recent Development
 Table 81. Otsuka Pharmaceutical India Private Limited Company Details
 Table 82. Otsuka Pharmaceutical India Private Limited Business Overview
 Table 83. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Product
 Table 84. Otsuka Pharmaceutical India Private Limited Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 85. Otsuka Pharmaceutical India Private Limited Recent Development
 Table 86. NUTRICHEM DIÄT + PHARMA GMBH Company Details
 Table 87. NUTRICHEM DIÄT + PHARMA GMBH Business Overview
 Table 88. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Product
 Table 89. NUTRICHEM DIÄT + PHARMA GMBH Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 90. NUTRICHEM DIÄT + PHARMA GMBH Recent Development
 Table 91. Delta Drugs Company Details
 Table 92. Delta Drugs Business Overview
 Table 93. Delta Drugs Enteral Nutrition Drug Product
 Table 94. Delta Drugs Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 95. Delta Drugs Recent Development
 Table 96. Baxter Company Details
 Table 97. Baxter Business Overview
 Table 98. Baxter Enteral Nutrition Drug Product
 Table 99. Baxter Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 100. Baxter Recent Development
 Table 101. Allergan Company Details
 Table 102. Allergan Business Overview
 Table 103. Allergan Enteral Nutrition Drug Product
 Table 104. Allergan Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 105. Allergan Recent Development
 Table 106. Actavis Inc. Company Details
 Table 107. Actavis Inc. Business Overview
 Table 108. Actavis Inc. Enteral Nutrition Drug Product
 Table 109. Actavis Inc. Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 110. Actavis Inc. Recent Development
 Table 111. Grifols, S.A. Company Details
 Table 112. Grifols, S.A. Business Overview
 Table 113. Grifols, S.A. Enteral Nutrition Drug Product
 Table 114. Grifols, S.A. Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 115. Grifols, S.A. Recent Development
 Table 116. Vifor Pharma Company Details
 Table 117. Vifor Pharma Business Overview
 Table 118. Vifor Pharma Enteral Nutrition Drug Product
 Table 119. Vifor Pharma Revenue in Enteral Nutrition Drug Business (2020-2025) & (US$ Million)
 Table 120. Vifor Pharma Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Enteral Nutrition Drug Picture
 Figure 2. Global Enteral Nutrition Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Enteral Nutrition Drug Market Share by Type: 2024 VS 2031
 Figure 4. Adults Features
 Figure 5. Children Features
 Figure 6. Global Enteral Nutrition Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Enteral Nutrition Drug Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Pharmaceutical Companies Case Studies
 Figure 11. Others Case Studies
 Figure 12. Enteral Nutrition Drug Report Years Considered
 Figure 13. Global Enteral Nutrition Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Enteral Nutrition Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Enteral Nutrition Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Enteral Nutrition Drug Market Share by Players in 2024
 Figure 17. Global Top Enteral Nutrition Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteral Nutrition Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Enteral Nutrition Drug Revenue in 2024
 Figure 19. North America Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Enteral Nutrition Drug Market Share by Country (2020-2031)
 Figure 21. United States Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Enteral Nutrition Drug Market Share by Country (2020-2031)
 Figure 25. Germany Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Enteral Nutrition Drug Market Share by Region (2020-2031)
 Figure 33. China Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Enteral Nutrition Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Enteral Nutrition Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Enteral Nutrition Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Hospira Inc Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 49. Fresenius Kabi Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 50. Danone Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 51. Knowmedical Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 52. Nestlé Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 53. B. Braun Melsungen AG Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 54. Abbott Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 55. Otsuka Pharmaceutical India Private Limited Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 56. NUTRICHEM DIÄT + PHARMA GMBH Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 57. Delta Drugs Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 58. Baxter Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 59. Allergan Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 60. Actavis Inc. Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 61. Grifols, S.A. Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 62. Vifor Pharma Revenue Growth Rate in Enteral Nutrition Drug Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Enteral Nutrition Preparation Market Research Report 2024
Global Enteral Nutrition and Parenteral Nutrition Market Research Report 2024
Global Enteral Feeding Tube Market Research Report 2025
Global Enteral Nutrition System Market Research Report 2025
Global Enteral Tube Feeding Nutrition Formula Market Research Report 2025
Global Enteral Nutritional Products Market Research Report 2024
Global Enteral Nutrition EN Solutions Market Research Report 2024
Global Oral and Enteral Nutrition System Market Research Report 2025
Enteral Feeding Administration Sets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enteral Nutrition Bags Market Research Report 2024
Global Enteral Nutritional Powder Market Research Report 2025
Global Enteral Nutrition Infusion Set Market Research Report 2024
Global Enteral Nutrition Medical Devices Market Research Report 2024
Enteral Feeding Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Enteral Feeding Device Used for Gastroenterology Market Insights Forecast to 2030
Global Short Peptide Enteral Nutrition Agents Market Research Report 2024
Global Enteral Feeding Device Used for Oncology Market Insights Forecast to 2030
Global Medical Enteral Nutrition Pump Market Research Report 2025
Global Tube Feeding Enteral Nutrition Market Research Report 2024
Global Nutritional Therapy Consumables Market Research Report 2024

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global OTC Hydrotalcite Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18S16538
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Women's Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14W1499
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Beef Protein Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39Y12110
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions